Name
Panel Discussion: Strategic Guidance on Animal Health Regulatory Pathways
Date & Time
Tuesday, June 15, 2021, 11:00 AM - 11:45 AM
Speakers
Klaus Hellmann - Argenta
Laura Treml VMD PhD - knoell
Jonathan Hare - Clinglobal
Terri Wasmoen - Animal Clinical Investigation, LLC
Audrey Sue-Lavoie - Paul Dick & Associates Ltd.
Laura Treml VMD PhD - knoell
Jonathan Hare - Clinglobal
Terri Wasmoen - Animal Clinical Investigation, LLC
Audrey Sue-Lavoie - Paul Dick & Associates Ltd.
![Klaus Hellmann](http://assets.swoogo.com/uploads/thumb/543239-5f1abcf9110c4.jpg)
![Laura Treml VMD PhD](http://assets.swoogo.com/uploads/thumb/862908-60105f72e0abd.jpg)
![Jonathan Hare](http://assets.swoogo.com/uploads/thumb/874463-601813c91e898.jpg)
![Terri Wasmoen](http://assets.swoogo.com/uploads/thumb/1206736-60c756fb034fc.jpg)
![Audrey Sue-Lavoie](http://assets.swoogo.com/uploads/thumb/1178584-60b913fbb2bd8.jpg)
Description
This panel with provide the audience with strategic guidance on how to approach the regulatory pathways for animal health.
- Regulation of biologics in the US (i.e. jurisdiction between CVB and CVM – and why you might want one or the other)
- New requirements from CVB regarding immunotherapeutics (VSM 800.126)
- Medical device regulation – or lack thereof
Virtual Session Link